Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Plourde Louis

31 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 15 Safety 9 Receptor Pharmacology 8 Mechanism of Action 7 Anxiety 7 Pharmacology 6 Treatment-Resistant Depression 5 End-of-Life Distress 5 Clinical Trial 4 Adverse Events 4 Observational Study 4 Brain Imaging 4

Journals

ClinicalTrials.gov 7 Palliative Medicine 1 SLEEPJ 1 Neuropharmacology 1 ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) 1 Psychology International 1 La Revue du praticien 1 Psychoactives 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23 Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01 A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for DepressionClinicalTrials.gov · 2026-05-20 0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEPJ · 2026-05-08 Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanismsNeuropharmacology · 2026-05-01 Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted TherapiesThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · 2026-03-16 Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19 Precision Functional Brain Mapping to Understand the Mechanisms of PsilocybinClinicalTrials.gov · 2025-10-31 A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From MethamphetamineClinicalTrials.gov · 2025-10-07 [Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].La Revue du praticien · 2025-10-01 Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01 Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08 0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart StudySLEEP · 2025-04-30 Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.Journal of Parkinson's disease · 2025-03-01 Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-21 Novel treatments for anorexia nervosa: Insights from neuroplasticity research.European eating disorders review: the journal of the Eating Disorders Association · 2024-11-01 What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.Palliative & supportive care · 2024-10-01 Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.Clinical case reports · 2024-09-01 Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01 Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04 UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBINIBRO Neuroscience Reports · 2023-10-01 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24 Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.Fungal genetics and biology: FG & B · 2023-03-01 SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for DepressionClinicalTrials.gov · 2023-01-30 Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01 Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-04-01 The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and PsilocybinLiving World, Journal of the Trinidad and Tobago Field Naturalists' Club · 2007-12-31 SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.ChemInform · 2005-12-13 SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.Bioorganic & medicinal chemistry letters · 2005-10-15 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.Science (New York, N.Y.) · 1967-11-03

Author directory